Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons

P R Blank, M Schwenkglenks, T D Szucs, P R Blank, M Schwenkglenks, T D Szucs

Abstract

Background: The primary objective of this study was to measure influenza vaccination coverage rates in the general population, including children, and in high-risk groups of five European countries during the season 2007/2008. An additional aim was to analyze coverage trends over seven consecutive seasons and to gain an understanding of the primary drivers and barriers to immunization.

Methods: Community-based telephone and mail surveys have been conducted in the UK, Germany, Italy, France, and Spain, yearly, since 2001/2002. Approximately 2,000 individuals per country and season were interviewed who were considered to be representative of the adult population aged 14 years and older. Data on the vaccination status of children were obtained by proxy interviews. The questionnaire used was essentially the same for all seven seasons. Five target groups were identified for the study: (1) persons aged > or = 65 years; (2) elderly suffering from a chronic illness; (3) patients suffering from a chronic illness; (4) persons working in the health care sector; (5) children.

Results: In the season 2007/2008, vaccination coverage rates in the general population remained stable in Germany. Compared to the coverage rates of the previous season, increases of 3.7%, 2.0%, and 1.8% were observed for the UK, Spain, and France, respectively, while a decrease of -1.5% was observed for Italy. Across all five countries, vaccination rates in the predefined target groups decreased to some extent (elderly) or increased slightly (chronically ill and health care workers). Vaccination rates among children varied strongly between countries and ranged from 6.1% in UK to 19.3% in Germany. The most powerful motivation for getting vaccinated in all countries was advice from a family doctor (58.6%) and the perception of influenza as a serious illness (51.9%). The major reasons why individuals did not become vaccinated were (1) the feeling of not being likely to catch influenza (39.5%) and (2) never having considered the option of being vaccinated (35.8%).

Conclusions: The change in general influenza vaccination coverage in the 2007/2008 season compared to the previous season was small, but decreases were seen in some target groups. The underlying motivations for and against vaccination did not substantially change. An effort to activate those driving forces that would encourage vaccination as well as dealing with barriers that tend to prevent it may help enhance coverage rates in Europe in the future.

References

    1. Vaccine. 2002 Jun 7;20(19-20):2562-78
    1. Expert Rev Vaccines. 2008 Jul;7(5):679-87
    1. Euro Surveill. 2008 Oct 23;13(43):
    1. BMC Public Health. 2008 Aug 01;8:272
    1. Vaccine. 2007 Jan 15;25(5):780-7
    1. J Infect Dis. 1994 Jan;169(1):68-76
    1. Euro Surveill. 2008 Jun 26;13(26):
    1. Vaccine. 2007 Nov 14;25(46):7931-8
    1. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003941
    1. Am J Prev Med. 1999 Apr;16(3):173-7
    1. Vaccine. 2008 Oct 16;26(44):5633-40
    1. Public Health. 2006 Nov;120(11):1074-80
    1. Pediatrics. 2008 Jul;122(1):e260-5
    1. Epidemiol Infect. 2006 Feb;134(1):71-8
    1. Vaccine. 2006 Nov 17;24(47-48):7003-8
    1. MMWR Recomm Rep. 2006 Jul 28;55(RR-10):1-42
    1. Lancet Infect Dis. 2004 Feb;4(2):75-83
    1. N Engl J Med. 2006 Dec 14;355(24):2523-32
    1. Vaccine. 2006 Jan 30;24(5):622-8
    1. JAMA. 1994 Dec 7;272(21):1661-5
    1. Annu Rev Public Health. 2007;28:113-26
    1. Pediatr Infect Dis J. 2004 Mar;23(3):189-97
    1. JAMA. 2000 Oct 4;284(13):1677-82
    1. Am J Med. 2008 Jul;121(7 Suppl 2):S28-35
    1. Vaccine. 2005 Oct 17;23(43):5055-63
    1. Am J Prev Med. 2000 Apr;18(3):215-8
    1. N Engl J Med. 1998 May 14;338(20):1459-61
    1. BMC Infect Dis. 2007 Dec 10;7:144
    1. Pharmacoeconomics. 1999;16 Suppl 1:63-71
    1. BMC Public Health. 2004 Aug 11;4:36
    1. N Engl J Med. 2007 Oct 4;357(14):1373-81
    1. Scand J Infect Dis. 2008;40(3):266-8
    1. Vaccine. 2005 Oct 25;23(44):5133-43

Source: PubMed

3
Abonner